• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢相关脂肪性肝病与阻塞性睡眠呼吸暂停之间的关联:一项横断面研究。

Association Between Metabolic-Associated Fatty Liver Disease and Obstructive Sleep Apnea: A Cross-Sectional Study.

作者信息

Huang Jiefeng, Chen Lida, Li Xiuling, Chen Menglan, Lin Ting, Chen Gongping

机构信息

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Fujian Medical University, Fujian Medical University, Fuzhou, People's Republic of China.

Institute of Respiratory Disease, Fujian Medical University, Fujian Medical University, Fuzhou, People's Republic of China.

出版信息

Nat Sci Sleep. 2023 Feb 28;15:49-57. doi: 10.2147/NSS.S398971. eCollection 2023.

DOI:10.2147/NSS.S398971
PMID:36879664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9985450/
Abstract

AIM

Emerging evidence has revealed that obstructive sleep apnea (OSA) is an independent risk factor for the development of a variety of adverse metabolic disease states. In this study, we evaluated the association between OSA severity and metabolic dysfunction-associated fatty liver disease (MAFLD) among Asian populations.

MATERIALS AND METHODS

This was a cross-sectional, single-center study. The study cohort consisted of patients undergoing polysomnography and abdominal ultrasonography. Logistic regression analysis was used to evaluate the independent risk factors of MAFLD in patients with OSA.

RESULTS

A total of 1065 patients (277 non-MAFLD and 788 MAFLD) were included in the study. The prevalence of MAFLD in non-OSA, mild-moderate OSA, and severe OSA patients was 58.16%, 72.41%, and 78.0%, respectively ( < 0.001). We identified significant differences in body mass index (BMI), apnea-hypopnea index (AHI), oxygen desaturation index (ODI), and lowest O saturation (LaSO) between non-MAFLD and MAFLD patients (all < 0.001). After adjusting for confounding variables, we used multivariate regression analysis to show that BMI, ODI, and triglyceride (TG) levels independently predicted the occurrence of MAFLD (odds ratio [OR] = 1.234, < 0.001; OR = 1.022, = 0.013; OR = 1.384, = 0.001, respectively). Moreover, stratified analysis according to BMI indicated that TG levels were the predominant risk factor for MAFLD in a group of patients with a BMI < 23 kg/m, while BMI, ODI, TG levels, and total cholesterol (TC) were the major risk factors for MAFLD in a group of patients with a BMI ≥ 23 kg/m (all < 0.05).

CONCLUSION

OSA-associated chronic intermittent hypoxia was independently associated with the risk of MAFLD, especially in OSA patients with a BMI ≥ 23 kg/m, suggesting that oxidative stress might play an important role in the pathogenesis of MAFLD in patients with OSA.

摘要

目的

新出现的证据表明,阻塞性睡眠呼吸暂停(OSA)是多种不良代谢疾病状态发生的独立危险因素。在本研究中,我们评估了亚洲人群中OSA严重程度与代谢功能障碍相关脂肪性肝病(MAFLD)之间的关联。

材料与方法

这是一项横断面单中心研究。研究队列包括接受多导睡眠图和腹部超声检查的患者。采用逻辑回归分析评估OSA患者发生MAFLD的独立危险因素。

结果

本研究共纳入1065例患者(277例非MAFLD患者和788例MAFLD患者)。非OSA、轻中度OSA和重度OSA患者中MAFLD的患病率分别为58.16%、72.41%和78.0%(<0.001)。我们发现非MAFLD患者和MAFLD患者在体重指数(BMI)、呼吸暂停低通气指数(AHI)、氧饱和度下降指数(ODI)和最低血氧饱和度(LaSO)方面存在显著差异(均<0.001)。在调整混杂变量后,我们使用多因素回归分析表明,BMI、ODI和甘油三酯(TG)水平独立预测MAFLD的发生(优势比[OR]=1.234,<0.001;OR=1.022,=0.013;OR=1.384,=0.001)。此外,根据BMI进行分层分析表明,在BMI<23kg/m的患者组中,TG水平是MAFLD的主要危险因素,而在BMI≥23kg/m的患者组中,BMI、ODI、TG水平和总胆固醇(TC)是MAFLD的主要危险因素(均<0.05)。

结论

OSA相关的慢性间歇性缺氧与MAFLD的风险独立相关,尤其是在BMI≥23kg/m的OSA患者中,这表明氧化应激可能在OSA患者MAFLD的发病机制中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39bf/9985450/83977e090de2/NSS-15-49-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39bf/9985450/83977e090de2/NSS-15-49-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39bf/9985450/83977e090de2/NSS-15-49-g0001.jpg

相似文献

1
Association Between Metabolic-Associated Fatty Liver Disease and Obstructive Sleep Apnea: A Cross-Sectional Study.代谢相关脂肪性肝病与阻塞性睡眠呼吸暂停之间的关联:一项横断面研究。
Nat Sci Sleep. 2023 Feb 28;15:49-57. doi: 10.2147/NSS.S398971. eCollection 2023.
2
Association of Obstructive Sleep Apnea with Nocturnal Hypoxemia in Metabolic-Associated Fatty Liver Disease Patients: A Cross-sectional Analysis of Record-based Data.代谢相关脂肪性肝病患者阻塞性睡眠呼吸暂停与夜间低氧血症的关联:基于记录数据的横断面分析
J Family Med Prim Care. 2021 Aug;10(8):3105-3110. doi: 10.4103/jfmpc.jfmpc_412_21. Epub 2021 Aug 27.
3
Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults.非肥胖成年人阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病之间的关系。
Sleep Breath. 2016 May;20(2):529-35. doi: 10.1007/s11325-015-1232-9. Epub 2015 Jul 15.
4
Association Between the Severity of Nocturnal Hypoxia in Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Damage.阻塞性睡眠呼吸暂停低通气综合征夜间低氧血症严重程度与非酒精性脂肪肝损伤的关系
Hepat Mon. 2015 Nov 28;15(11):e32655. doi: 10.5812/hepatmon.32655. eCollection 2015 Nov.
5
The association between glycometabolism and nonalcoholic fatty liver disease in patients with obstructive sleep apnea.糖代谢与阻塞性睡眠呼吸暂停患者非酒精性脂肪肝的关系。
Sleep Breath. 2019 Mar;23(1):373-378. doi: 10.1007/s11325-018-1744-1. Epub 2018 Oct 22.
6
Interrelationships between body mass, oxygen desaturation, and apnea-hypopnea indices in a sleep clinic population.在睡眠诊所人群中,体重、氧减饱和度和呼吸暂停低通气指数之间的相互关系。
Sleep. 2012 Jan 1;35(1):89-96. doi: 10.5665/sleep.1592.
7
Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia.阻塞性睡眠呼吸暂停对脂肪肝的影响:慢性间歇性低氧的作用。
Respir Care. 2012 Feb;57(2):244-9. doi: 10.4187/respcare.01184. Epub 2011 Jul 12.
8
Hyperlipidaemia prevalence and cholesterol control in obstructive sleep apnoea: Data from the European sleep apnea database (ESADA).阻塞性睡眠呼吸暂停中的高脂血症患病率和胆固醇控制:来自欧洲睡眠呼吸暂停数据库(ESADA)的数据。
J Intern Med. 2019 Dec;286(6):676-688. doi: 10.1111/joim.12952. Epub 2019 Jul 25.
9
[Metabolic profile in obese patients with obstructive sleep apnea. A comparison between patients with insulin resistance and with insulin sensitivity].[阻塞性睡眠呼吸暂停肥胖患者的代谢特征。胰岛素抵抗患者与胰岛素敏感患者的比较]
Pneumologia. 2014 Apr-Jun;63(2):100-2, 104-6.
10
Waist-hip ratio is an independent predictor of moderate-to-severe OSA in nonobese males: a cross-sectional study.腰臀比是预测非肥胖男性中重度阻塞性睡眠呼吸暂停的独立指标:一项横断面研究。
BMC Pulm Med. 2022 Apr 22;22(1):151. doi: 10.1186/s12890-022-01886-3.

引用本文的文献

1
Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis.代谢功能障碍相关脂肪性肝病与心房颤动:发病机制综述
World J Cardiol. 2025 Jun 26;17(6):106147. doi: 10.4330/wjc.v17.i6.106147.
2
Nephrological, Pulmonary, and Dermatological Complications in the Context of MAFLD/NAFLD: A Narrative Review.MAFLD/NAFLD背景下的肾脏、肺部和皮肤并发症:一项叙述性综述
Metabolites. 2025 Apr 14;15(4):272. doi: 10.3390/metabo15040272.
3
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.

本文引用的文献

1
The Causal Effects of Lipid Profiles on Sleep Apnea.血脂水平对睡眠呼吸暂停的因果效应。
Front Nutr. 2022 Jun 21;9:910690. doi: 10.3389/fnut.2022.910690. eCollection 2022.
2
Sleep Duration, Sleep Quality, and the Development of Nonalcoholic Fatty Liver Disease: A Cohort Study.睡眠时间、睡眠质量与非酒精性脂肪性肝病的发生发展:一项队列研究。
Clin Transl Gastroenterol. 2021 Oct 19;12(10):e00417. doi: 10.14309/ctg.0000000000000417.
3
Association of Obstructive Sleep Apnea with Nocturnal Hypoxemia in Metabolic-Associated Fatty Liver Disease Patients: A Cross-sectional Analysis of Record-based Data.
亚太肝脏研究协会代谢功能障碍相关脂肪性肝病诊断和管理临床实践指南
Hepatol Int. 2025 Apr;19(2):261-301. doi: 10.1007/s12072-024-10774-3. Epub 2025 Feb 27.
4
Association between hemoglobin and non-alcoholic fatty liver disease (NAFLD) in United States adults: Results from NHANES 2017-2020.美国成年人血红蛋白与非酒精性脂肪性肝病(NAFLD)之间的关联:2017 - 2020年美国国家健康与营养检查调查(NHANES)结果
Prev Med Rep. 2024 Jun 15;44:102798. doi: 10.1016/j.pmedr.2024.102798. eCollection 2024 Aug.
5
MAFLD as part of systemic metabolic dysregulation.MAFLD作为全身代谢失调的一部分。
Hepatol Int. 2024 Oct;18(Suppl 2):834-847. doi: 10.1007/s12072-024-10660-y. Epub 2024 Apr 9.
6
Intermittent hypoxia induces hepatic senescence through promoting oxidative stress in a mouse model.间歇性低氧通过促进氧化应激诱导小鼠肝衰老。
Sleep Breath. 2024 Mar;28(1):183-191. doi: 10.1007/s11325-023-02878-1. Epub 2023 Jul 15.
代谢相关脂肪性肝病患者阻塞性睡眠呼吸暂停与夜间低氧血症的关联:基于记录数据的横断面分析
J Family Med Prim Care. 2021 Aug;10(8):3105-3110. doi: 10.4103/jfmpc.jfmpc_412_21. Epub 2021 Aug 27.
4
Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.中国城市人群代谢相关脂肪性肝病的流行情况及其危险因素:一项横断面对比研究。
BMC Gastroenterol. 2021 May 10;21(1):212. doi: 10.1186/s12876-021-01782-w.
5
Role of Insulin Resistance in MAFLD.胰岛素抵抗在 MAFLD 中的作用。
Int J Mol Sci. 2021 Apr 16;22(8):4156. doi: 10.3390/ijms22084156.
6
Metabolic-associated fatty liver disease and lipoprotein metabolism.代谢相关性脂肪性肝病与脂蛋白代谢。
Mol Metab. 2021 Aug;50:101238. doi: 10.1016/j.molmet.2021.101238. Epub 2021 Apr 20.
7
The metabolic profiles and body composition of lean metabolic associated fatty liver disease.瘦型代谢相关脂肪性肝病的代谢特征和身体成分。
Hepatol Int. 2021 Apr;15(2):405-412. doi: 10.1007/s12072-021-10147-0. Epub 2021 Feb 4.
8
Association between obstructive sleep apnea and non-alcoholic fatty liver disease in pediatric patients: a meta-analysis.儿童阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病的相关性:荟萃分析。
Pediatr Obes. 2021 Mar;16(3):e12718. doi: 10.1111/ijpo.12718. Epub 2020 Sep 2.
9
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义:国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
10
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD:代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.